Literature DB >> 2416270

Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.

K A Jaeckle, F Graus, A Houghton, C Cardon-Cardo, S L Nielsen, J B Posner.   

Abstract

Sera from 6 of 12 patients with paraneoplastic cerebellar degeneration (PCD) contained anti-Purkinje cell antibodies, as determined by indirect immunofluorescence on frozen sections of normal human cerebellum. Samples of cerebrospinal fluid from 2 of the patients with serum antibodies were tested, and both specimens contained anti-Purkinje cell antibody. The anti-Purkinje cell antibodies were polyclonal, fixed complement, and were present in all patients at serum dilutions of 1:1,000 or greater. Antibody activity could not be suppressed by preabsorption of sera with human or animal brain and tissue powders or with fresh crude human cerebellar extracts. No anti-Purkinje cell antibodies were detected in control sera from 167 neurologically normal cancer patients, 32 normal volunteers, 10 patients with other causes of cerebellar degeneration, or 8 patients with other paraneoplastic neurological diseases. Preliminary evidence suggests that the Purkinje antigen is a protein that is often concentrated in the periphery of the cytoplasm in disc-shaped structures. Patients with antibodies often developed signs of PCD near the time of detection of the tumor and had relentless progression of neurological disease. Patients without antibodies frequently had cancer for months to years before PCD developed, and often had spontaneous stabilization of neurological disease with time. Four patients without and 3 patients with antibodies underwent plasmapheresis without response.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2416270     DOI: 10.1002/ana.410180513

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  38 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Pursuing an occult carcinoma in a patient with subacute cerebellar degeneration and anticerebellar antibodies. Need for vigorous follow-up.

Authors:  J E Greenlee; H R Brashear; K A Jaeckle; A Geleris; K Jordan
Journal:  West J Med       Date:  1992-02

3.  Autoimmune encephalopathy.

Authors:  Richard J Caselli; Joseph F Drazkowski; Dean M Wingerchuk
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

4.  Antineuronal antibodies in small cell lung carcinoma--a significance for paraneoplastic syndromes?

Authors:  W Grisold; M Drlicek; W Popp; K Jellinger
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Opsoclonus as a presenting symptom in thymic carcinoma.

Authors:  M Schwartz; B Sharf; J Zidan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-06       Impact factor: 10.154

6.  Anti-Purkinje cell cytoplasmic and neuronal nuclear antibodies aid diagnosis of paraneoplastic autoimmune neurological disorders.

Authors:  V A Lennon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-12       Impact factor: 10.154

7.  Anti-CNS antibodies in neurological and psychiatric disorders.

Authors:  A V Plioplys; J Thibault; J P Bouchard; C Cockburn; R Hawkes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-11       Impact factor: 10.154

Review 8.  Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

Authors:  R B Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  Paraneoplastic cerebellar degeneration with a circulating antibody against neurons and non-neuronal cells.

Authors:  H Tomimoto; J M Brengman; T Yanagihara
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

10.  Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration.

Authors:  E J Dropcho; Y T Chen; J B Posner; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.